STAAR Surgical ROE 2010-2024 | STAA

Current and historical return on equity (ROE) values for STAAR Surgical (STAA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
STAAR Surgical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.02B $0.43B 5.45%
2024-06-30 $0.02B $0.41B 4.34%
2024-03-31 $0.02B $0.39B 4.23%
2023-12-31 $0.02B $0.39B 6.04%
2023-09-30 $0.02B $0.38B 5.97%
2023-06-30 $0.03B $0.35B 7.71%
2023-03-31 $0.03B $0.34B 10.20%
2022-12-31 $0.04B $0.34B 13.00%
2022-09-30 $0.04B $0.32B 14.21%
2022-06-30 $0.04B $0.30B 13.67%
2022-03-31 $0.03B $0.28B 12.95%
2021-12-31 $0.03B $0.26B 11.70%
2021-09-30 $0.02B $0.25B 10.28%
2021-06-30 $0.02B $0.24B 10.10%
2021-03-31 $0.01B $0.21B 5.70%
2020-12-31 $0.01B $0.20B 3.32%
2020-09-30 $0.01B $0.19B 5.25%
2020-06-30 $0.01B $0.18B 4.31%
2020-03-31 $0.01B $0.17B 7.77%
2019-12-31 $0.01B $0.16B 8.81%
2019-09-30 $0.01B $0.15B 5.69%
2019-06-30 $0.01B $0.14B 5.17%
2019-03-31 $0.01B $0.14B 4.45%
2018-12-31 $0.01B $0.13B 5.59%
2018-09-30 $0.00B $0.13B 5.95%
2018-06-30 $0.00B $0.05B 8.84%
2018-03-31 $0.00B $0.05B 2.38%
2017-12-31 $-0.00B $0.04B -5.03%
2017-09-30 $-0.00B $0.04B -5.19%
2017-06-30 $-0.01B $0.04B -13.25%
2017-03-31 $-0.01B $0.04B -15.89%
2016-12-31 $-0.01B $0.04B -31.58%
2016-09-30 $-0.01B $0.04B -33.99%
2016-06-30 $-0.01B $0.04B -33.55%
2016-03-31 $-0.01B $0.04B -33.12%
2015-12-31 $-0.01B $0.04B -18.06%
2015-09-30 $-0.01B $0.04B -23.53%
2015-06-30 $-0.01B $0.04B -25.97%
2015-03-31 $-0.01B $0.04B -25.64%
2014-12-31 $-0.01B $0.04B -22.36%
2014-09-30 $-0.01B $0.04B -17.18%
2014-06-30 $-0.00B $0.04B -7.50%
2014-03-31 $-0.00B $0.04B -2.61%
2013-12-31 $0.00B $0.04B 0.00%
2013-09-30 $0.00B $0.04B 0.00%
2013-06-30 $-0.00B $0.04B -3.01%
2013-03-31 $-0.00B $0.03B -3.10%
2012-12-31 $-0.00B $0.03B -3.15%
2012-09-30 $0.00B $0.03B 0.00%
2012-06-30 $0.00B $0.03B 0.00%
2012-03-31 $0.00B $0.03B 3.51%
2011-12-31 $0.00B $0.03B 3.77%
2011-09-30 $0.00B $0.03B 0.00%
2011-06-30 $-0.00B $0.03B -4.30%
2011-03-31 $-0.00B $0.02B -17.98%
2010-12-31 $0.00B $0.02B 0.00%
2010-09-30 $0.00B $0.02B 0.00%
2010-06-30 $-0.00B $0.02B -4.55%
2010-03-31 $0.00B $0.02B 0.00%
2009-12-31 $-0.01B $0.02B -30.00%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.315B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36